2022-501857-35-00
EU Clinical Trials Information System
- Trial ID
- T-ctis-2022-501857-35-00
- Registry
- EU Clinical Trials Information System
- CTIS number
- 2022-501857-35-00
- Sponsor, as registered
- Universitair Ziekenhuis Gent
- Phase
- Therapeutic exploratory (Phase II)
- Indication
- treatment-resistant depression
- Status
- Authorised
- Start date
- 22/04/2024
- Primary completion
- CTIS does not publish one.
- Member states concerned
- Belgium
- Sites
- 1
Member states whose regulator has a decision on this trial.
euclinicaltrials.euctis registryverified 2026-10-19
Notes on the record
New to data/trials.csv (no row for this CT number on main as of 2026-10-19); found by CTIS public search productName=psilocybin. Fields read from the CTIS public API retrieve record on 2026-10-19 17:33 CEST (publishDate 2026-08-14T03:33); site_count is the sum of trialSites across authorizedPartsII; codes not decoded; no primary completion date published.
Cited in
No published issue cites this registry number.